These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1049 related items for PubMed ID: 10327065
1. Differential involvement of the CD95 (Fas/APO-1) receptor/ligand system on apoptosis induced by the wild-type p53 gene transfer in human cancer cells. Fukazawa T, Fujiwara T, Morimoto Y, Shao J, Nishizaki M, Kadowaki Y, Hizuta A, Owen-Schaub LB, Roth JA, Tanaka N. Oncogene; 1999 Apr 01; 18(13):2189-99. PubMed ID: 10327065 [Abstract] [Full Text] [Related]
2. Induction of Fas expression and augmentation of Fas/Fas ligand-mediated apoptosis by the synthetic retinoid CD437 in human lung cancer cells. Sun SY, Yue P, Hong WK, Lotan R. Cancer Res; 2000 Nov 15; 60(22):6537-43. PubMed ID: 11103825 [Abstract] [Full Text] [Related]
3. Alterations of Fas (APO-1/CD 95) gene and its relationship with p53 in non small cell lung cancer. Boldrini L, Faviana P, Pistolesi F, Gisfredi S, Di Quirico D, Lucchi M, Mussi A, Angeletti CA, Baldinotti F, Fogli A, Simi P, Basolo F, Fontanini G. Oncogene; 2001 Oct 04; 20(45):6632-7. PubMed ID: 11641789 [Abstract] [Full Text] [Related]
4. Induction of Fas-mediated apoptosis in p53-transfected human colon carcinoma cells. Tamura T, Aoyama N, Saya H, Haga H, Futami S, Miyamoto M, Koh T, Ariyasu T, Tachi M, Kasuga M. Oncogene; 1995 Nov 16; 11(10):1939-46. PubMed ID: 7478511 [Abstract] [Full Text] [Related]
5. Induction of p53-regulated genes in lung cancer cells: implications of the mechanism for adenoviral p53-mediated apoptosis. Gu J, Zhang L, Swisher SG, Liu J, Roth JA, Fang B. Oncogene; 2004 Feb 12; 23(6):1300-7. PubMed ID: 14676844 [Abstract] [Full Text] [Related]
6. Differential activation of the Fas/CD95 pathway by Ad-p53 in human gliomas. Cerrato JA, Khan T, Koul D, Lang FF, Conrad CA, Yung WK, Liu TJ. Int J Oncol; 2004 Feb 12; 24(2):409-17. PubMed ID: 14719118 [Abstract] [Full Text] [Related]
7. Chimeric tumor suppressor 1, a p53-derived chimeric tumor suppressor gene, kills p53 mutant and p53 wild-type glioma cells in synergy with irradiation and CD95 ligand. Naumann U, Kügler S, Wolburg H, Wick W, Rascher G, Schulz JB, Conseiller E, Bähr M, Weller M. Cancer Res; 2001 Aug 01; 61(15):5833-42. PubMed ID: 11479223 [Abstract] [Full Text] [Related]
8. p53-mediated up-regulation of CD95 is not involved in genotoxic drug-induced apoptosis of human breast tumor cells. Ruiz-Ruiz MC, López-Rivas A. Cell Death Differ; 1999 Mar 01; 6(3):271-80. PubMed ID: 10200578 [Abstract] [Full Text] [Related]
9. p53 promotes selection for Fas-mediated apoptotic resistance. Maecker HL, Koumenis C, Giaccia AJ. Cancer Res; 2000 Aug 15; 60(16):4638-44. PubMed ID: 10969818 [Abstract] [Full Text] [Related]
10. Modification of gene products involved in resistance to apoptosis in metastatic colon cancer cells: roles of Fas, Apaf-1, NFkappaB, IAPs, Smac/DIABLO, and AIF. Huerta S, Heinzerling JH, Anguiano-Hernandez YM, Huerta-Yepez S, Lin J, Chen D, Bonavida B, Livingston EH. J Surg Res; 2007 Sep 15; 142(1):184-94. PubMed ID: 17603079 [Abstract] [Full Text] [Related]
11. Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand. Mitsiades N, Poulaki V, Tseleni-Balafouta S, Koutras DA, Stamenkovic I. Cancer Res; 2000 Aug 01; 60(15):4122-9. PubMed ID: 10945619 [Abstract] [Full Text] [Related]
12. CD95-mediated apoptosis is impaired at receptor level by cellular FLICE-inhibitory protein (long form) in wild-type p53 human ovarian carcinoma. Mezzanzanica D, Balladore E, Turatti F, Luison E, Alberti P, Bagnoli M, Figini M, Mazzoni A, Raspagliesi F, Oggionni M, Pilotti S, Canevari S. Clin Cancer Res; 2004 Aug 01; 10(15):5202-14. PubMed ID: 15297424 [Abstract] [Full Text] [Related]
13. High-efficiency gene transfer and high-level expression of wild-type p53 in human lung cancer cells mediated by recombinant adenovirus. Zhang WW, Fang X, Mazur W, French BA, Georges RN, Roth JA. Cancer Gene Ther; 1994 Mar 01; 1(1):5-13. PubMed ID: 7621238 [Abstract] [Full Text] [Related]
14. Alterations of Fas (Apo-1/CD95) gene in non-small cell lung cancer. Lee SH, Shin MS, Park WS, Kim SY, Kim HS, Han JY, Park GS, Dong SM, Pi JH, Kim CS, Kim SH, Lee JY, Yoo NJ. Oncogene; 1999 Jun 24; 18(25):3754-60. PubMed ID: 10391683 [Abstract] [Full Text] [Related]
15. Restoration of p53 expression sensitizes human papillomavirus type 16 immortalized human keratinocytes to CD95-mediated apoptosis. Aguilar-Lemarroy A, Gariglio P, Whitaker NJ, Eichhorst ST, zur Hausen H, Krammer PH, Rösl F. Oncogene; 2002 Jan 10; 21(2):165-75. PubMed ID: 11803460 [Abstract] [Full Text] [Related]
16. Colon carcinoma cells use different mechanisms to escape CD95-mediated apoptosis. von Reyher U, Sträter J, Kittstein W, Gschwendt M, Krammer PH, Möller P. Cancer Res; 1998 Feb 01; 58(3):526-34. PubMed ID: 9458101 [Abstract] [Full Text] [Related]
17. Role of p53 in regulating constitutive and X-radiation-inducible CD95 expression and function in carcinoma cells. Sheard MA, Uldrijan S, Vojtesek B. Cancer Res; 2003 Nov 01; 63(21):7176-84. PubMed ID: 14612511 [Abstract] [Full Text] [Related]
18. Activation of the Fas-FasL signaling pathway by MDA-7/IL-24 kills human ovarian cancer cells. Gopalan B, Litvak A, Sharma S, Mhashilkar AM, Chada S, Ramesh R. Cancer Res; 2005 Apr 15; 65(8):3017-24. PubMed ID: 15833826 [Abstract] [Full Text] [Related]
19. The CD95/CD95 ligand system is not the major effector in anticancer drug-mediated apoptosis. Tolomeo M, Dusonchet L, Meli M, Grimaudo S, D'Alessandro N, Papoff G, Ruberti G, Rausa L. Cell Death Differ; 1998 Sep 15; 5(9):735-42. PubMed ID: 10200532 [Abstract] [Full Text] [Related]
20. Reduced telomeric signals and increased telomeric associations in human lung cancer cell lines undergoing p53-mediated apoptosis. Mukhopadhyay T, Multani AS, Roth JA, Pathak S. Oncogene; 1998 Aug 20; 17(7):901-6. PubMed ID: 9780006 [Abstract] [Full Text] [Related] Page: [Next] [New Search]